Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma

BACKGROUND: In the era of cytokines, patients with brain metastases (BM) from renal cell carcinoma had a significantly shorter survival than patients without. Targeted agents (TA) have improved the outcome of patients with metastatic renal cell carcinoma (mRCC) however, their impact on patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogl, Ursula M, Bojic, Marija, Lamm, Wolfgang, Frischer, Josa M, Pichelmayer, Oskar, Kramer, Gero, Haitel, Andrea, Kitz, Klaus, Harmankaya, Kaan, Zielinski, Christoph C, Schmidinger, Manuela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942853/
https://www.ncbi.nlm.nih.gov/pubmed/20819239
http://dx.doi.org/10.1186/1471-2407-10-480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942853/
https://www.ncbi.nlm.nih.gov/pubmed/20819239
http://dx.doi.org/10.1186/1471-2407-10-480

Ejemplares similares